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Sir,  
In staphylococci, resistance to macrolides, lincosamides, and streptogramin B 
antibiotics (MLS phenotype) is caused by a ribosomal methylase encoded by the erm genes. 
Expression of resistance to clindamycin can be either inducible or constitutive. The inducible 
phenotype is expressed only in the presence of macrolides, and these strains appear to be 
susceptible to clindamycin in vitro. However, reports of treatment failures have led to 
concerns about the efficacy of clindamycin for strains with inducible (iMLS) phenotypes [1], 
especially when oral clindamycin may be used for outpatient treatment of infections caused 
by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). In Hong 
Kong, studies have showed that multiple lineages of CA-MRSA are emerging [2]. Here, we 
determine the prevalence of MLS phenotypes and their resistance determinants among our 
CA-MRSA isolates and compared them with methicillin-sensitive S. aureus (MSSA) and 
healthcare-associated (HA)-MRSA.    
Susceptibility of the isolates to erythromycin and clindamycin were determined by the 
disc diffusion method. The D-test was used to detect inducible resistance to clindamycin. 
Quality control strains were included on each day of testing. The relatedness of the strains 
were characterized by spa typing and/or multilocus sequencing. MRSA strains were 
additionally tested by SCCmec multiplex PCR [2,3]. Multiplex PCR assays for the erm A, 
ermB, ermC, mef and msrA genes were performed using previously described primers [4]. 
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A total of 422 S. aureus isolates including 185 MSSA group, 107 HA-MRSA and 130 
CA-MRSA isolates collected in Hong Kong during 2004-2007 from diverse sources were 
tested [2,3]. Overall, the erythromycin resistance rate was 36.7% (155/422) including 60.7% 
(65/107) for HA-MRSA, 26.9% (35/130) for CA-MRSA and 29.7% (55/185) for MSSA. 
Among erythromycin-resistant (ery-R) isolates, 24.5% (38/155) and 67.1% (104/155) had 
constitutive (cMLS phenotype) and inducible (iMLS phenotype) resistance to clindamycin, 
respectively. The remaining 13 erythromycin-resistant isolates (11 CA-MRSA and 2 MSSA) 
had the M phenotype (i.e. resistant to erythromycin only). Another four isolates (all CA-
MRSA) were resistant to clindamycin alone (L phenotype). The iMLS phenotype 
predominated among MSSA (78.1%, 43/55) and HA-MRSA (93.8%, 61/65), while the cMLS 
phenotype was prevalent among CA-MRSA (68.6%, 24/35).  
The 155 ery-R isolates were tested for the presence of MLS resistance genes (Table 1). 
At least one erm gene was detected in 98.6% (140/142) of the isolates with cMLS or iMLS 
phenotype. Among ery-R MSSA isolates, ermA gene (67.3%, 37/55) predominated, followed 
by ermC (18.2%, 10/55) and ermB (10.9%, 6/55). By comparison, 56.9% and 44.6% of the 
ery-R HA-MRSA were found to possess ermC and ermA, respectively. In CA-MRSA, the 
MLS phenotype was largely attributed to ermB and the M phenotype to msrA genes.  
In MRSA, the MLS determinants were largely distributed among clonally related 
strains. Thirty-one (86.1%) of the 36 ermC positive HA-MRSA isolates were of the 
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CC45/SCCmec IV/V clone (t1081 or related spa types). The remaining five ermC HA-MRSA 
isolates belonged to CC7/SCCmec V lineage (n=2, t1081), EMRSA-15 (n=2, ST22, t032) 
and ST188 (n=1, t198). Similarly, 86.2% (25/29) of the ermA positive and the singleton ermA 
+ ermC positive HA-MRSA isolates were of the CC5/SCCmec II clone (t002). For CA-
MRSA, all of the 20 ermB positive and two ermB + ermC positive isolates were of the 
CC59/SCCmec V clone. All the 11 msrA positive CA-MRSA isolates belonged to the 
ST8/SCCmec IV clone (i.e. USA300) and they have spa types t008 (n=9) or t2196 (n=2). 
Conversely, the MSSA strains with ermA, ermB or ermC genes were genetically diverse. 
Analysis of 28 ery-R MSSA isolates showed that they fell into 17 different spa types. Types 
with >1 isolates included t338 (n=7), t437 (n=3), t002 (n=2), t091 (n=2) and t127 (n=2). The 
following spa types had one isolate each: t012, t034, t1244, t1399, t2421, t337, t3485, t363, 
t732, t899 and t930.  
This study revealed distinctive patterns of erm and msrA genes among S. aureus 
populations. The majority of ery-R MSSA and HA-MRSA had the iMLS phenotype encoded 
by either the ermA or ermC genes. In contrast, ery-R CA-MRSA isolates often had the cMLS 
phenotype and ermB. The findings indicate both independent acquisitions of the erm genes as 
well as spread of specific resistant clones. As observed previously, ermA is usually inducible 
while ermB is expressed constitutively, and the expression of ermC may be either inducible 
or constitutive [5]. A small proportion of the ermA positive strains had the cMLS phenotype. 
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Such change from inducible to constitutive expression could possibly be due to gene 
duplication, deletion or point mutation in the erm regulatory regions [4]. With the exception 
of the CA-MRSA isolates related to the USA300 clone, the msrA was rare among the other S. 
aureus populations; suggesting that the gene may have been recently introduced to our 
community.  In conclusion, our findings demonstrate that emergence of CA-MRSA in our 
locality was associated with emergence of the ermB and msrA genes that were uncommon 
among the MSSA and HA-MRSA populations.  
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Table 1 
Prevalence of macrolide resistance genes among 155 erythromycin-resistant Staphylococcus 
aureus isolates, 2004-2007 
 
S. aureus group No (% by S. aureus group) 
 ermA ermB ermC msrA none 
MSSA (n=55)      
cMLS 0 6 (10.9) 4 (7.3)   
iMLS 37 (67.3) 0 6 (10.9)   
M 0 0 0 1 1 
HA-MRSA (n=65)      
cMLS 2 (3.1) 0 2 (3.1)   
iMLS 27 (41.5) 0 35 (53.8)a   
CA-MRSA (n=35)      
cMLS 0 22 (62.9) 2 (5.7)b  2 
M 0 0 0 11  
a One isolate positive for both ermA and ermC genes. 
b Two isolates positive for both ermB and ermC 
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